Back
EyePoint Pharmaceuticals Stock Price Chart
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
33
EYPT
EyePoint Pharmaceuticals
Last Price:
$7.23
Seasonality Move:
7.64%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing slight selling pressure.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.62 | Sell |
| 20-day SMA: | 8.29 | Sell |
| 50-day SMA: | 9.7 | Sell |
| 200-day SMA: | 11.63 | Sell |
| 8-day EMA: | 7.61 | Sell |
| 20-day EMA: | 8.25 | Sell |
| 50-day EMA: | 8.98 | Sell |
| 200-day EMA: | 10.9 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.64 | Sell |
| Relative Strength Index (14 RSI): | 34.11 | Sell |
| Chaikin Money Flow: | -639404 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.76 - 9.04) | Sell |
| Bollinger Bands (100): | (7.84 - 10.36) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 7.12 while EYPT 8-day simple moving average is 7.62, which is a Sell signal.
-
The stock price of EYPT is 7.12 while EyePoint Pharmaceuticals 20-day SMA is 8.29, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day simple moving average is 9.70 while EYPT share price is 7.12, making it a Sell technically.
-
EYPT stock price is 7.12 and EyePoint Pharmaceuticals 200-day simple moving average is 11.63, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
33
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a SellThe current EyePoint Pharmaceuticals [EYPT] share price is $7.12. The Score for EYPT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
485.9M
Price in USD:
7.12
Share Volume:
4.2M
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
30.99
52-Week Low:
6.90
Sell
33
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?The EyePoint Pharmaceuticals stock price is 7.12 USD today.
-
Will EYPT stock go up or go down?EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is EyePoint Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 7.12 while EYPT 8-day exponential moving average is 7.61, which is a Sell signal.
-
The stock price of EYPT is 7.12 while EyePoint Pharmaceuticals 20-day EMA is 8.25, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day exponential moving average is 8.98 while EYPT share price is 7.12, making it a Sell technically.
-
EYPT stock price is 7.12 and EyePoint Pharmaceuticals 200-day simple moving average is 10.90, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.31 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
-
EYPT Moving Average Covergence Divergence (MACD) indicator is -0.64, suggesting EyePoint Pharmaceuticals is a Sell
-
EyePoint Pharmaceuticals Relative Strength Index (RSI) is 34.11, which suggest EyePoint Pharmaceuticals is oversold
-
The Bollinger Bands (25) for EyePoint Pharmaceuticals is (7.76 - 9.04), which suggest EyePoint Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for EyePoint Pharmaceuticals is (7.84 - 10.36), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.